Advertisement

Novovax News

alt
SII is in talks with Novovax to develop a vaccine against monkeypox This has been confirmed by SII CEO Adar Poonawalla He said that SII is working with Novovax to develop a messenger RNA for monkeypox
alt
According to an official statement released by Novovax, the vaccine, also known as NVX-CoV2373, is manufactured and marketed in India by the Serum Institute of India (SII) under the brand name Covovax and is the first protein-based vaccine authorized for use in this age group in India.






Loading...
english news
NEWS ON ONE CLICK